1.
Decellularization and sterilization of porcine urinary bladder matrix for tissue engineering in the lower urinary tract
by Rosario, Derek J
Regenerative medicine, 2008-03-01, Vol.3 (2), p.145-156

2.
Cardiovascular risk in androgen suppression: underappreciated, under-researched and unresolved
by Bourke, Liam
Heart (British Cardiac Society), 2012-03, Vol.98 (5), p.345-348

3.
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled...
by Azzouzi, Abdel-Rahmène, Prof
The lancet oncology, 2016, Vol.18 (2), p.181-191

4.
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study
by Donovan, Jenny L
Journal of clinical epidemiology, 2019, Vol.113, p.200-213

5.
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
by Donovan, Jenny L
Journal of clinical epidemiology, 2018-04, Vol.96, p.35-46

6.
Cardiovascular risk in androgen suppression: underappreciated, under-researched and unresolved: Figure 1
by Bourke, Liam
Heart (British Cardiac Society), 2012-03-01, Vol.98 (5), p.345-348

7.
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
by Capeding, Maria Rosario, MD
The Lancet (British edition), 2014, Vol.384 (9951), p.1358-1365

8.
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
by Lane, J Athene, PhD
The lancet oncology, 2014, Vol.15 (10), p.1109-1118

9.
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19
by Bégin, Philippe
Nature medicine, 2022-01, Vol.28 (1), p.53-58

10.
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
by Bégin, Philippe
Nature medicine, 2022-01, Vol.28 (1), p.212-212

11.
Dogs as a Favored Host Choice of Anopheles gambiae sensu stricto (Diptera: Culicidae) of São Tomé, West Africa
by Sousa, Carla A
Journal of medical entomology, 2001-01, Vol.38 (1), p.122-125

12.
Dogs as a Favored Host Choice ofAnopheles gambiaesensu stricto (Diptera: Culicidae) of São Tomé, West Africa
by Sousa, Carla A.
Journal of medical entomology, 2001-01-01, Vol.38 (1), p.122-125
